Business Description
Promisemed Hangzhou Meditech Co Ltd
ISIN : CNE100007KR3
Total Employee Number:
527Compare
Compare
Traded in other countries / regions
920069.China IPO Date
2026-03-27Description
Promisemed Hangzhou Meditech Co Ltd is engaged in the Research, development, production and sales of diabetes care, universal drug delivery and infusion, and minimally invasive interventional medical devices.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 12.98 | |||||
Equity-to-Asset | 0.87 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.16 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 10.72 | |||||
Beneish M-Score | -2.49 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 16.5 | |||||
3-Year EBITDA Growth Rate | 15.2 | |||||
3-Year EPS without NRI Growth Rate | 15.2 | |||||
3-Year Book Growth Rate | 15.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 38.65 | |||||
9-Day RSI | 43.51 | |||||
14-Day RSI | 45.2 | |||||
3-1 Month Momentum % | -7.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.2 | |||||
Quick Ratio | 3.23 | |||||
Cash Ratio | 1.99 | |||||
Days Inventory | 79.11 | |||||
Days Sales Outstanding | 52.16 | |||||
Days Payable | 61.74 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.53 | |||||
Dividend Payout Ratio | 0.23 | |||||
Forward Dividend Yield % | 1.53 | |||||
5-Year Yield-on-Cost % | 1.51 | |||||
Shareholder Yield % | 4.08 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 21.6 | |||||
Operating Margin % | -17.54 | |||||
Net Margin % | 23.09 | |||||
EBITDA Margin % | -19.15 | |||||
FCF Margin % | 18.16 | |||||
OCF Margin % | 29.38 | |||||
ROE % | 14.83 | |||||
ROA % | 12.28 | |||||
ROIC % | -10.12 | |||||
3-Year ROIIC % | 18.98 | |||||
ROC (Joel Greenblatt) % | -13.97 | |||||
ROCE % | -11.16 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 15.19 | |||||
PE Ratio without NRI | 15.11 | |||||
PS Ratio | 3.5 | |||||
PB Ratio | 2.22 | |||||
Price-to-Tangible-Book | 2.29 | |||||
Price-to-Free-Cash-Flow | 18.67 | |||||
Price-to-Operating-Cash-Flow | 11.92 | |||||
EV-to-EBIT | -19.19 | |||||
EV-to-EBITDA | -19.19 | |||||
EV-to-Revenue | 3.68 | |||||
EV-to-FCF | 20.24 | |||||
Price-to-Graham-Number | 1.24 | |||||
| Price-to-Net-Current-Asset-Value | 7.3 | |||||
| Price-to-Net-Cash | 33.62 | |||||
Earnings Yield (Greenblatt) % | -5.21 | |||||
FCF Yield % | 4.4 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Promisemed Hangzhou Meditech Co Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 427.028 | ||
| EPS (TTM) (Â¥) | 2.192 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 45.2 | ||
| 14-Day ATR (Â¥) | 1.084285 | ||
| 20-Day SMA (Â¥) | 33.8865 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (Â¥) | 31.21 - 50 | ||
| Shares Outstanding (Mil) | 52.92 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Promisemed Hangzhou Meditech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Promisemed Hangzhou Meditech Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 0.510000 Cash Dividend | 2026-06-15 | 36.50 (-0.27%) |
Show
Entries
Promisemed Hangzhou Meditech Co Ltd Frequently Asked Questions
What is Promisemed Hangzhou Meditech Co Ltd(BJSE:920069)'s stock price today?
The current price of BJSE:920069 is ¥33.28. The 52 week high of BJSE:920069 is ¥50.00 and 52 week low is ¥31.21.
When is next earnings date of Promisemed Hangzhou Meditech Co Ltd(BJSE:920069)?
The next earnings date of Promisemed Hangzhou Meditech Co Ltd(BJSE:920069) is .
Does Promisemed Hangzhou Meditech Co Ltd(BJSE:920069) pay dividends? If so, how much?
The Dividend Yield %  of Promisemed Hangzhou Meditech Co Ltd(BJSE:920069) is 1.53% (As of Today), Highest Dividend Payout Ratio of Promisemed Hangzhou Meditech Co Ltd(BJSE:920069) was 0.23. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Promisemed Hangzhou Meditech Co Ltd(BJSE:920069) is 1.53%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Promisemed Hangzhou Meditech Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers